Mineralys Therapeutics, Inc.
MLYS
Revenue
0.00
0.000.00%
-Assets
205.90M
▼-62.35M▼-23.24%
3 Months ChangeLiabilities
14.65M
▼-16.68M▼-53.24%
3 Months ChangeFree Cash Flow
-19.20M
▼-6.42M▼-50.28%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-30
Form 8-K
ID: 0001933414-24-000050
2024-09-25
Form 8-K
ID: 0001933414-24-000044
2024-08-13
Form 10-Q
ID: 0001933414-24-000039
2024-08-13
Form 8-K
ID: 0001933414-24-000038
2024-06-14
Form 8-K
ID: 0001933414-24-000028
2024-06-10
Form 8-K
ID: 0001933414-24-000025
2024-05-31
Form 8-K
ID: 0001933414-24-000024
2024-05-22
Form 8-K
ID: 0001933414-24-000017
2024-05-09
Form 10-Q
ID: 0001933414-24-000016
2024-05-09
Form 8-K
ID: 0001933414-24-000015